Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies
Cardiovascular diseases (CVD) are the leading causes of mortality in patients with diabetes, and many factors, including hypertension, contribute to this high prevalence of CVD. The current evidence regarding these diseases is quickly expanding, especially in the vascular mechanisms that predispose...
Պահպանված է:
| Ձևաչափ: | Online |
|---|---|
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | ONIX_20240704_9783725810055_6 |
| Ցուցիչներ: |
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| _version_ | 1869518248683241472 |
|---|---|
| collection | Directory of Open Access Books |
| description | Cardiovascular diseases (CVD) are the leading causes of mortality in patients with diabetes, and many factors, including hypertension, contribute to this high prevalence of CVD. The current evidence regarding these diseases is quickly expanding, especially in the vascular mechanisms that predispose someone to both conditions. Furthermore, several novel therapies, such as sodium glucose co-transporter 2 inhibitors, have recently beenshown to have benefits against CVD in patients with type 2 diabetes. With these reasons in mind, the need for updated clinical studies in these fields to optimize the outcomes of patients with diabetes, hypertension, and cardiovascular diseases arises. Finally, as we know that diabetes, hypertension, and especially CVD are associated with severity and mortality in patients with COVID-19 infection, we also invited colleagues around the world to report their clinical insights with these comorbidities and COVID-19 in order to provide support in this fundamental area during the pandemic. |
| format | Online |
| id | doab-20.500.12854ir-139210 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1392102024-07-04T09:28:02Z Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies Hung, Ming-Jui hypertension cardiovascular risk factors arterial stiffness Framingham score atherosclerosis pulse wave velocity subendocardial viability ratio obesity paradox heart failure body mass index diabetes ejection fraction angina coronary artery disease inflammation vasospasm heart rate mortality diabetes mellitus diabetic kidney disease exosomes microRNA urinary three-dimensional anthropometrics waist circumference chest width adiponectin leptin idarucizumab dabigatran reversal agents peripheral artery disease biomarkers cardiovascular risk neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio lymphocyte-to-C-reactive protein ratio systematic review meta-analysis type 2 diabetes mellitus Fufang danshen dripping pill blood viscosity hyperglycemia east Asian traditional medicine integrative medicine herbal medicine case report GLP-1 insulin cardiovascular renal n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine Cardiovascular diseases (CVD) are the leading causes of mortality in patients with diabetes, and many factors, including hypertension, contribute to this high prevalence of CVD. The current evidence regarding these diseases is quickly expanding, especially in the vascular mechanisms that predispose someone to both conditions. Furthermore, several novel therapies, such as sodium glucose co-transporter 2 inhibitors, have recently beenshown to have benefits against CVD in patients with type 2 diabetes. With these reasons in mind, the need for updated clinical studies in these fields to optimize the outcomes of patients with diabetes, hypertension, and cardiovascular diseases arises. Finally, as we know that diabetes, hypertension, and especially CVD are associated with severity and mortality in patients with COVID-19 infection, we also invited colleagues around the world to report their clinical insights with these comorbidities and COVID-19 in order to provide support in this fundamental area during the pandemic. 2024-07-04T09:27:59Z 2024-07-04T09:27:59Z 2024 book ONIX_20240704_9783725810055_6 9783725810055 9783725810062 https://directory.doabooks.org/handle/20.500.12854/139210 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9205 https://mdpi.com/books/pdfview/book/9205 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1006-2 10.3390/books978-3-7258-1006-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725810055 9783725810062 160 open access |
| spellingShingle | hypertension cardiovascular risk factors arterial stiffness Framingham score atherosclerosis pulse wave velocity subendocardial viability ratio obesity paradox heart failure body mass index diabetes ejection fraction angina coronary artery disease inflammation vasospasm heart rate mortality diabetes mellitus diabetic kidney disease exosomes microRNA urinary three-dimensional anthropometrics waist circumference chest width adiponectin leptin idarucizumab dabigatran reversal agents peripheral artery disease biomarkers cardiovascular risk neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio lymphocyte-to-C-reactive protein ratio systematic review meta-analysis type 2 diabetes mellitus Fufang danshen dripping pill blood viscosity hyperglycemia east Asian traditional medicine integrative medicine herbal medicine case report GLP-1 insulin cardiovascular renal n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title_full | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title_fullStr | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title_full_unstemmed | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title_short | Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights, Mechanisms, and Pharmacotherapies |
| title_sort | diabetes hypertension and cardiovascular disease clinical insights mechanisms and pharmacotherapies |
| topic | hypertension cardiovascular risk factors arterial stiffness Framingham score atherosclerosis pulse wave velocity subendocardial viability ratio obesity paradox heart failure body mass index diabetes ejection fraction angina coronary artery disease inflammation vasospasm heart rate mortality diabetes mellitus diabetic kidney disease exosomes microRNA urinary three-dimensional anthropometrics waist circumference chest width adiponectin leptin idarucizumab dabigatran reversal agents peripheral artery disease biomarkers cardiovascular risk neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio lymphocyte-to-C-reactive protein ratio systematic review meta-analysis type 2 diabetes mellitus Fufang danshen dripping pill blood viscosity hyperglycemia east Asian traditional medicine integrative medicine herbal medicine case report GLP-1 insulin cardiovascular renal n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine |
| topic_facet | hypertension cardiovascular risk factors arterial stiffness Framingham score atherosclerosis pulse wave velocity subendocardial viability ratio obesity paradox heart failure body mass index diabetes ejection fraction angina coronary artery disease inflammation vasospasm heart rate mortality diabetes mellitus diabetic kidney disease exosomes microRNA urinary three-dimensional anthropometrics waist circumference chest width adiponectin leptin idarucizumab dabigatran reversal agents peripheral artery disease biomarkers cardiovascular risk neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio lymphocyte-to-C-reactive protein ratio systematic review meta-analysis type 2 diabetes mellitus Fufang danshen dripping pill blood viscosity hyperglycemia east Asian traditional medicine integrative medicine herbal medicine case report GLP-1 insulin cardiovascular renal n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine |
| url | ONIX_20240704_9783725810055_6 |